The AvertD test is intended to be used prior to first exposure to oral opioids in patients considered for a 4-30 day prescription for acute pain.
The AvertD test is intended to be used prior to first exposure to oral opioids in patients considered for a 4-30 day prescription for acute pain.
The ketamine molecule is not FDA-approved in any formulation for the treatment of psychiatric disorders.
First-time generics are available for drugs that treat COPD, HIV, hypertension, and more.
Moderna and Pfizer boosters have been updated to target the omicron variant.
Novavax COVID-19 Vaccine, Adjuvanted will require two doses given three weeks apart.
A mix-up between 30 mg and 60 mg tablets could cause severe adverse events.
Undeclared muscle relaxants and anti-inflammatory drugs could interact with a patient’s care.
The public comment period is underway for this action, which could help with safer drug disposal.
Buprenorphine is an opioid used to treat pain, as well as opioid-use disorder.
Molnupiravir, Paxlovid, and AZD7442 have shown promise in Phase 3 trials.